Sodium Cation
Active ingredient
Sold as Elliotts B
- Drug class
- -
- Availability
- Prescription only
- Routes
- Intrathecal
- Markets covered
- 1
- Products on record
- 1
Overview
Plain-language summary, compiled from the cited regulatory records
Sodium Cation is a substance used in a pharmaceutical product [1]. This product is approved as a diluent for the intrathecal administration of methotrexate sodium and cytarabine [1]. Its approved use is for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma [1].
This product is available under the brand name Elliotts B [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | October 16, 2024 |
USUnited States· FDA
1 product
Uses
INDICATIONS AND USAGE
Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.
How to take
DOSAGE AND ADMINISTRATION
See product labeling for methotrexate sodium and cytarabine. Elliotts B Solution is intended for intrathecal administration only. Elliotts B Solution does not contain antibacterial preservatives and introduction of contaminated solutions into the cerebrospinal fluid may have extremely serious consequences.
Therefore, administration of intrathecal solutions should be accomplished as soon as possible after preparation. A sterile filter-needle should be used to withdraw the contents of the ampule. Intrathecal drug products should be inspected visually for particulate matter and discoloration prior to administration.
Preparation and Administration Precautions Elliotts B Solution is a diluent for the cytotoxic anticancer agents, methotrexate sodium and cytarabine. Care should be exercised in the handling and preparation of infusion solutions with these products.
)
This is not medical advice. Consult a qualified healthcare professional.
Side effects & warnings
ADVERSE REACTIONS
Adverse reactions may occur with any given intrathecal injection due to the chemotherapy or the technique of intrathecal administration. ) Preservative-free methotrexate sodium and cytarabine should be used to minimize adverse reactions due to preservatives.
If an adverse reaction does occur, discontinue the administration, evaluate the patient, institute appropriate therapeutic countermeasures and, if possible, save the remainder of the unused solution(s) for examination.
WARNINGS
Intrathecal administration of drugs such as methotrexate sodium and cytarabine should be performed by personnel skilled in the technique of lumbar puncture under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents.
The labeling for methotrexate sodium and cytarabine should be consulted.
This is not medical advice. Consult a qualified healthcare professional.
Who should not take it
CONTRAINDICATIONS
None known.
This is not medical advice. Consult a qualified healthcare professional.
Brands in United States (1)
Sources & citations
- [1]FDA DailyMed · 08036dbd-55b3-47… · revised October 16, 2024 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.